26th Jun 2006 17:46
United Drug PLC26 June 2006 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug Plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i)3 Name of person discharging managerial 4 State whether notification relates to a person responsibilities/director: connected with a person discharging managerial responsibilities/director named in 3 and identify the Mr. Vincent Long connected person: N/A5 Indicate whether the notification is in 6 Description of shares (including class) debentures or respect of a holding of the person referred derivatives or financial instruments relating to to in 3 or 4 above or in respect of a shares non-beneficial interest Granting of stock options relating to Ordinary Shares As per 3 above of 0.05 each7 Name or registered shareholder(s) and, if 8 State the nature of the transaction more than one, member of shares held by each of them Granting of Stock Options N/A9 Number of shares, debentures or financial 10 Percentage of issued class acquired (treasury shares instruments relating to shares acquired of that class should not be taken into account when calculating percentage) N/A N/A11 Number of shares, debentures or financial 12 Percentage of issued class disposed (treasury shares instruments relating to shares disposed of that class should not be taken into account when calculating percentage) N/A N/A13 Price per share or value of transaction 14 Date and place of transaction N/A 23rd June 200615 Total holding following notification and 16 Date issuer informed of transaction total percentage holding following notification (any treasury shares should not N/A be taken into account when calculating percentage) N/A If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 23rd June 2006 40,000 From 23 June 2011 to 22 June 201619 Total amount paid (if any) for grant of the option 20 Description of shares or debentures involved (class and number) N/A Ordinary shares of 0.05 Shares21 Exercise price (if fixed at time of grant) or 22 Total number of shares or debentures over indication that the price is to be fixed at the which options are held following time of exercise notification €3.32 286,500 €0.05 Ordinary Shares23 Any additional information 24 Name of contact and telephone number for queries N/A Claire Heeley (01-4637721) Name and signature of authorised officer of issuer responsible for making notification __________Claire Heeley__________________________________________ Date of notification ________26 June 2006___________________________ SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug Plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i)3 Name of person discharging managerial 4 State whether notification relates to a person responsibilities/director: connected with a person discharging managerial responsibilities/director named in 3 and identify the Mr. Alan Ralph connected person: N/A5 Indicate whether the notification is in 6 Description of shares (including class) debentures or respect of a holding of the person referred derivatives or financial instruments relating to to in 3 or 4 above or in respect of a shares non-beneficial interest Granting of stock options relating to Ordinary Shares As per 3 above of 0.05 each7 Name or registered shareholder(s) and, if 8 State the nature of the transaction more than one, member of shares held by each of them Granting of Stock Options N/A9 Number of shares, debentures or financial 10 Percentage of issued class acquired (treasury shares instruments relating to shares acquired of that class should not be taken into account when calculating percentage) N/A N/A11 Number of shares, debentures or financial 12 Percentage of issued class disposed (treasury shares instruments relating to shares disposed of that class should not be taken into account when calculating percentage) N/A N/A13 Price per share or value of transaction 14 Date and place of transaction N/A 23rd June 200615 Total holding following notification and 16 Date issuer informed of transaction total percentage holding following notification (any treasury shares should not N/A be taken into account when calculating percentage) N/A If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 23rd June 2006 45,000 From 23 June 2009 to 22 June 2016 40,000 From 23 June 2011 to 22 June 201619 Total amount paid (if any) for grant of the option 20 Description of shares or debentures involved (class and number) N/A Ordinary shares of 0.05 Shares21 Exercise price (if fixed at time of grant) or 22 Total number of shares or debentures over indication that the price is to be fixed at the which options are held following time of exercise notification €3.32 343,500 €0.05 Ordinary Shares23 Any additional information 24 Name of contact and telephone number for queries N/A Claire Heeley (01-4637721) Name and signature of authorised officer of issuer responsible for making notification __________Claire Heeley__________________________________________ Date of notification ________26 June 2006___________________________ SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug Plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i)3 Name of person discharging managerial 4 State whether notification relates to a person responsibilities/director: connected with a person discharging managerial responsibilities/director named in 3 and identify the Mr. Luke Brehony connected person: N/A5 Indicate whether the notification is in 6 Description of shares (including class) debentures or respect of a holding of the person referred derivatives or financial instruments relating to to in 3 or 4 above or in respect of a shares non-beneficial interest Granting of stock options relating to Ordinary Shares As per 3 above of 0.05 each7 Name or registered shareholder(s) and, if 8 State the nature of the transaction more than one, member of shares held by each of them Granting of Stock Options N/A9 Number of shares, debentures or financial 10 Percentage of issued class acquired (treasury shares instruments relating to shares acquired of that class should not be taken into account when calculating percentage) N/A N/A11 Number of shares, debentures or financial 12 Percentage of issued class disposed (treasury shares instruments relating to shares disposed of that class should not be taken into account when calculating percentage) N/A N/A13 Price per share or value of transaction 14 Date and place of transaction N/A 23rd June 200615 Total holding following notification and 16 Date issuer informed of transaction total percentage holding following notification (any treasury shares should not N/A be taken into account when calculating percentage) N/A If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 23rd June 2006 45,000 From 23 June 2009 to 22 June 2016 40,000 From 23 June 2011 to 22 June 201619 Total amount paid (if any) for grant of the option 20 Description of shares or debentures involved (class and number) N/A Ordinary shares of 0.05 Shares21 Exercise price (if fixed at time of grant) or 22 Total number of shares or debentures over indication that the price is to be fixed at the which options are held following time of exercise notification €3.32 321,000 €0.05 Ordinary Shares23 Any additional information 24 Name of contact and telephone number for queries N/A Claire Heeley (01-4637721) Name and signature of authorised officer of issuer responsible for making notification __________Claire Heeley__________________________________________ Date of notification ________26 June 2006___________________________ SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug Plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i)3 Name of person discharging managerial 4 State whether notification relates to a person responsibilities/director: connected with a person discharging managerial responsibilities/director named in 3 and identify the Mr. Liam Logue connected person: N/A5 Indicate whether the notification is in 6 Description of shares (including class) debentures or respect of a holding of the person referred derivatives or financial instruments relating to to in 3 or 4 above or in respect of a shares non-beneficial interest Granting of stock options relating to Ordinary Shares As per 3 above of 0.05 each7 Name or registered shareholder(s) and, if 8 State the nature of the transaction more than one, member of shares held by each of them Granting of Stock Options N/A9 Number of shares, debentures or financial 10 Percentage of issued class acquired (treasury shares instruments relating to shares acquired of that class should not be taken into account when calculating percentage) N/A N/A11 Number of shares, debentures or financial 12 Percentage of issued class disposed (treasury shares instruments relating to shares disposed of that class should not be taken into account when calculating percentage) N/A N/A13 Price per share or value of transaction 14 Date and place of transaction N/A 23rd June 200615 Total holding following notification and 16 Date issuer informed of transaction total percentage holding following notification (any treasury shares should not N/A be taken into account when calculating percentage) N/A If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 23rd June 2006 40,000 From 23 June 2009 to 22 June 2016 30,000 From 23 June 2011 to 22 June 201619 Total amount paid (if any) for grant of the option 20 Description of shares or debentures involved (class and number) N/A Ordinary shares of 0.05 Shares21 Exercise price (if fixed at time of grant) or 22 Total number of shares or debentures over indication that the price is to be fixed at the which options are held following time of exercise notification €3.32 185,000 €0.05 Ordinary Shares23 Any additional information 24 Name of contact and telephone number for queries N/A Claire Heeley (01-4637721) Name and signature of authorised officer of issuer responsible for making notification __________Claire Heeley__________________________________________ Date of notification ________26 June 2006___________________________ SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug Plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (i)3 Name of person discharging managerial 4 State whether notification relates to a person responsibilities/director: connected with a person discharging managerial responsibilities/director named in 3 and identify the Mr. Mick Dunne connected person: N/A5 Indicate whether the notification is in 6 Description of shares (including class) debentures or respect of a holding of the person referred derivatives or financial instruments relating to to in 3 or 4 above or in respect of a shares non-beneficial interest Granting of stock options relating to Ordinary Shares As per 3 above of 0.05 each7 Name or registered shareholder(s) and, if 8 State the nature of the transaction more than one, member of shares held by each of them Granting of Stock Options N/A9 Number of shares, debentures or financial 10 Percentage of issued class acquired (treasury shares instruments relating to shares acquired of that class should not be taken into account when calculating percentage) N/A N/A11 Number of shares, debentures or financial 12 Percentage of issued class disposed (treasury shares instruments relating to shares disposed of that class should not be taken into account when calculating percentage) N/A N/A13 Price per share or value of transaction 14 Date and place of transaction N/A 23rd June 200615 Total holding following notification and 16 Date issuer informed of transaction total percentage holding following notification (any treasury shares should not N/A be taken into account when calculating percentage) N/A If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 23rd June 2006 45,000 From 23 June 2009 to 22 June 201619 Total amount paid (if any) for grant of the option 20 Description of shares or debentures involved (class and number) N/A Ordinary shares of 0.05 Shares21 Exercise price (if fixed at time of grant) or 22 Total number of shares or debentures over indication that the price is to be fixed at the which options are held following time of exercise notification €3.32 267,500 €0.05 Ordinary Shares23 Any additional information 24 Name of contact and telephone number for queries N/A Claire Heeley (01-4637721) Name and signature of authorised officer of issuer responsible for making notification __________Claire Heeley__________________________________________ Date of notification ________26 June 2006___________________________ Notes: This form is intended for use by an issuer to make a RISnotification required by (the Market Abuse Rules(1) and) section 53 (as extendedby section 64 of the Companies Act 1990) or entered into the issuer's registerin accordance with section 59 of the Companies Act 1990. (1) An issuer making a notification in respect of a transaction relatingto the shares or debentures of the issuer should complete boxes 1 to 16, 23 and24. (2) An issuer making a notification in respect of a derivative relating tothe shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14,16,23 and 24. (3) An issuer making a notification in respect of options granted to adirector/person discharging managerial responsibilities should complete boxes 1to 3 and 17 to 24 (4) An issuer making a notification in respect of a financial instrumentrelating to the shares of the issuer (other than a debenture) should completethe boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. (1) Please note that the requirement to make a notification under the MarketAbuse Rules does not apply until 1 October 2005. Schedule 11 may be subject toamendment prior to 1 October 2005 to bring it in line with IFSRA's 'Notificationof Transactions of Directors/Persons Discharging Managerial Responsibility andConnected Persons' under the Market Abuse Disclosure Rules. This announcement has been issued through the Companies Announcement Service of The Irish Stock Exchange -------------------------- This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
UDG.L